Physician profile
Anders H Berg
NPI 1730251950
$12,937.90
in general payments reported to CMS, 2019-2025
8 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Clinical Pathology/Laboratory Medicine provider received nationally (typical 2025 total: $114).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.78 · 2021: $37.98 · 2022: $1,512 · 2023: $6,375 · 2024: $4,470 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $10K · Food and Beverage: $737 · Consulting Fee: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,250.00 |
| Food and Beverage | $737.31 |
| Consulting Fee | $348.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher Scientific Company L.L.C. | $10,250.00 | 2023-2024 | Procalcitonin |
| Diasorin INC. | $1,500.00 | 2022 | |
| Kaneka Medical America LLC | $379.04 | 2024 | |
| Becton, Dickinson and Company | $348.00 | 2025 | |
| Abbott Laboratories | $176.27 | 2020-2025 | Alinity |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2023 | |
| Biocartis US, INC | $90.85 | 2024 | Idylla |
| E.R. Squibb & Sons, L.L.C. | $68.74 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anders Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.